In line with announcements from the Financial Conduct Authority (FCA), publication of 24 of the 35 LIBOR settings ceased from January 1, 2022.
1-, 3- and 6-month sterling and yen LIBOR settings will continue for the duration of 2022 on a ‘synthetic’ basis.
Synthetic JPY LIBOR will cease at the end of 2022.
On September 29, 2022, FCA announced their decision on the cessation of 1- and 6-month synthetic sterling LIBOR. Publication will continue until end-March 2023, after which these settings will permanently cease.
On November 23, 2022, FCA announced their decision to continue to require IBA to publish the 3-month synthetic sterling LIBOR setting until end-March 2024, after which it will cease permanently.
USD LIBOR cessation or non-representativeness from June 30, 2023
Five US dollar LIBOR settings (O/N, 1M, 3M, 6M &12M) continue to be calculated using panel bank submissions until mid-2023, although its use for new business will be restricted from end-2021, with limited exceptions.
O/N and 12M USD LIBOR last publication date will be June 30, 2023.
On November 23, 2022 – FCA announced a consultation on their proposal to require LIBOR’s administrator, IBA, to continue to publish the 1-, 3- and 6-month US dollar LIBOR settings under an unrepresentative ‘synthetic’ methodology until end-September 2024. After this, publication would cease permanently.
The Federal Reserve Board, Federal Deposit Insurance Corporation and Office of the Comptroller of the Currency has previously issued supervisory guidance encouraging banks to cease entering into new contracts that use USD LIBOR as a reference rate as soon as practicable and in any event by December 31, 2021. USD Dealing will be permitted in certain use cases as outlined in the SR 20-27 Interagency Statement on LIBOR Transition.
On October 20, 2021 - Fed, OCC, FDIC, CFPB, NCUA, state bank and credit union regulators issued a joint statement on managing the LIBOR transition. The statement includes: Clarification regarding new LIBOR contracts: A new contract would include an agreement that (i) creates additional LIBOR exposure for a supervised institution or (ii) extends the term of an existing LIBOR contract. A draw on an existing agreement that is legally enforceable (e.g., a committed credit facility) would not be viewed as a new contract. For more information on considerations when assessing appropriateness of alternative reference rates, expectations for fallback language and additional considerations, please visit the statement.
On December 16th, 2022 – the Federal Reserve Board adopted the final rule that implements Adjustable Interest Rate (LIBOR) Act by identifying benchmark rates based on SOFR (Secured Overnight Financing Rate) that will replace LIBOR in certain financial contracts after June 30, 2022.
On December 16th, 2022 – the FSB published a progress report on the transition from LIBOR and other benchmarks encouraging final transition to robust reference rates as cessation of remaining LIBOR panels approaches.
On November 23, 2022 - FCA released a further consultation and announcements on the wind-down of LIBOR. They proposing to require LIBOR’s administrator, IBA, to continue to publish the 1-, 3- and 6-month US dollar LIBOR settings under an unrepresentative ‘synthetic’ methodology until end-September 2024. After this, publication would cease permanently. For sterling LIBOR, they intend to continue to require IBA to publish the 3-month synthetic sterling LIBOR setting until end-March 2024, after which it will cease permanently.
On November 14, 2022 - ICE Benchmark Administration (IBA) announced that it will cease the publication of all USD LIBOR ICE Swap Rate “runs” (i.e. USD LIBOR Rates 1100, USD LIBOR Spreads 1100 and USD LIBOR 1500) for all tenors immediately after publication on June 30, 2023.
On November 9, 2022 - ARRC posted their November 9, 2022 meeting readout.
On November 1, 2022 - Refinitiv announced that it will cease publication of Tokyo Swap Rate (for swaps referencing TIBOR). The final publication will be at 15:30 (Tokyo time) on March 31, 2023.
On October 13, 2022 – ARRC released Loan Remediation Survey results encouraging transition progress in U.S. Dollar (USD) LIBOR Business Loans but reinforce the need for timely action.
On October 10, 2022, The European Money Markets Institute (EMMI) announced the launch of EFTERM® from November 14 2022. This is a prominent event given that this new fallback rate will help EURIBOR® users to comply with the relevant legal requirements under the EU Benchmarks Regulation.
On September 29, 2022 - The FCA announced their decision on the cessation of 1- and 6-month synthetic sterling LIBOR. Publication will continue until end-March 2023, after which these settings will permanently cease. For synthetic yen LIBOR, market participants should be prepared for publication to cease permanently at end-2022, as set out previously.
On September 8, 2022 - ISDA guidance on the IBOR fallback rates was published by Bloomberg and the interaction among RFR publications, IBOR fallback publications and the ISDA Definitions has been published on the ISDA Website.
On September 8, 2022 – ARRC posted their September 8, 2022 meeting readout.
On August 31, 2022 - IBA published a consultation on the potential cessation of the publication of the USD LIBOR ICE Swap Rate for all tenors immediately after publication on June 30, 2023. Due date October 7, 2022
On August 24, 2022- The Bank of England published a Policy Statement on changes to the UK Derivatives Clearing Obligation further to interest rates benchmark reform
In August 2022 - CME confirmed the approach for converting USD LIBOR cleared swaps.
On August 16, 2022 - The FCA released a statement encouraging market participants to continue transition of LIBOR-linked bonds.
On August 12, 2022 - The CFTC Issued its Final Rule Modifying the Swap Clearing Requirement in support of the transition from LIBOR and Other Interbank Offered Rates to Alternative Reference Rates.
On July 19, 2022 - Federal Reserve Board (FRB) issued a notice of proposed rulemaking implementing the Adjustable Interest Rate (LIBOR) Act enacted by Congress earlier this year
Changes to Interbank Offered Rates (IBORs) and other benchmark rates: Certain interest rate benchmarks are, or may in the future become, subject to ongoing international, national and other regulatory guidance, reform and proposals for reform. For more information, please consult: https://www.jpmorgan.com/global/disclosures/interbank_offered_rates
This is placeholder for podcast series
See results from The e-Trading Edit, an institutional survey where traders across asset classes and regions share their top predictions. How do yours compare?
J.P. Morgan’s Research team leverages cutting-edge technologies and innovative tools to bring clients industry-leading analysis and investment advice.
FOR INSTITUTIONAL & PROFESSIONAL CLIENTS ONLY – This material is from a Sales and Trading department and is not a product of the Research Department.
This material has been prepared by personnel in the Sales and Trading Departments of one or more affiliates of JPMorgan Chase & Co. (together, “J.P. Morgan”) and not by J.P. Morgan’s Research Department and therefore, has not been prepared in accordance with legal requirements to promote the independence of research, including but not limited to, the prohibition on the dealing ahead of the dissemination of investment research. It is not a research report and is not intended as such. It is for distribution to institutional and professional clients only and is not intended for retail customer use.
It is provided on a confidential basis and may not be reproduced, redistributed or disseminated, in whole or in part, without the prior written consent of J.P. Morgan. Any unauthorized use is strictly prohibited.
Unless otherwise specifically stated, any views or opinions expressed herein are solely those of the individual author and/or the specific Sales and Trading area from which it originates and may differ from the views or opinions expressed by other areas of J.P. Morgan, including the Research Department.
This material is provided for information purposes only and does not bind J.P. Morgan in any way. It is not intended as a recommendation (except to the extent it is an “investment recommendation” under MAR (as defined below)) or an offer or solicitation (except to the extent covered by CFTC Rules (as defined below)) for the purchase or sale of any security or financial instrument, or to enter into a transaction involving any financial instrument or trading strategy, or as an official confirmation or official valuation of any transaction mentioned herein. Any pricing information provided is indicative only and does not reflect a level where J.P. Morgan is prepared to execute a trade. J.P. Morgan is not an advisor. Nothing in this material should be construed as investment, tax, legal, accounting, regulatory or other advice (including within the meaning of Section 15B of the Securities Exchange Act of 1934) or as creating a fiduciary relationship.
MAR Disclosure: Where this material is an “investment recommendation” as that term is defined in Article 3(1)(35) of the EU and UK Market Abuse Regulation (“MAR”), distribution of this material is subject to the relevant provisions of MAR. For more information, please consult: www.jpmm.com/#mardisclosures.
Research Disclosure: This material is not, and is not intended to be, a “research report”, “investment research” or “independent research” as may be defined in applicable laws and regulations worldwide. However, it may constitute “research” as defined in Recital 28 of the Commission Delegated Directive (EU) 2017/593 and in the Financial Conduct Authority’s Handbook.
Derivatives Disclosure: Where distribution of this material is subject to the rules of the U.S. Commodity Futures Trading Commission (“CFTC”), it is a “solicitation” of derivatives business generally only as that term is used within CFTC Rule 1.71 and 23.605 promulgated under the U.S. Commodity Exchange Act (the “CFTC Rules”).
Options Disclosure: Structured securities, options, futures and other derivatives are complex instruments and may involve a high degree of risk. Before entering into any such transactions, please ensure that you have read and understood the Options Clearing Corporation’s Characteristics and Risks of Standardized Options, also known as the options disclosure document (ODD) available at: http://www.theocc.com/about/publications/character-risks.jsp.
Analytics Disclosure: Past or simulated past performance is not indicative of future results. Any modelling scenario analysis or other forward-looking information herein is intended to illustrate hypothetical results based on certain assumptions, information and/or financial data (not all of which will be specified herein). J.P. Morgan does not guarantee expressly or impliedly the accuracy or completeness of any information and/or financial data used herein. Further, the information and/or financial data used by JPM may not be representative of all information and/or financial data available to J.P. Morgan. The information and/or financial data available herein may change at any time without notice to you. Actual events or conditions may differ materially from those assumed; therefore, actual results are not guaranteed and J.P. Morgan disclaims any responsibility or liability whatsoever for the quality, accuracy or completeness of the information herein, and for any reliance on, or use of this material in any way. The actual results you see will be based on a number of assumption not all of which will be explicitly disclosed to you.
Exchange Traded Fund (“ETF”) Disclosure: Each U.S. registered ETF has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission. Each non-U.S. ETF will have its own offering documents as required by applicable law. No offer or sale of the ETFs described may be made except pursuant to the prospectus or offering documents, as applicable. The ETF’s prospectus and/or offering documents are available through the ETF issuer’s website; you should read these carefully before deciding to invest.
Transactions involving securities, financial instruments and strategies mentioned herein may not be suitable for all investors. You are solely responsible for deciding whether any investment or transaction is suitable for you based upon your investment goals, financial situation and tolerance for risk. If you deem it necessary, you must seek independent professional advice to ascertain the investment, legal, tax, accounting, regulatory or other consequences before investing or transacting.
Past or simulated past performance (including back-testing) is not indicative of future results. The investments discussed may fluctuate in price or value. Changes in rates of exchange may have an adverse effect on the value of investments. Any modelling, scenario analysis or other forward-looking information herein (such as projected cashflows, yields or returns) is intended to illustrate hypothetical results based on certain assumptions (not all of which will be specified herein). Actual events or conditions may differ materially from those assumed; therefore, actual results are not guaranteed.
All market prices, data and other information (including that which may be derived from third party sources believed to be reliable) are not warranted as to completeness or accuracy and are subject to change without notice. J.P. Morgan disclaims any responsibility or liability to the fullest extent permitted by applicable law, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. The information contained herein is as of the date and time referenced only, and J.P. Morgan does not undertake any obligation to update such information.
J.P. Morgan may have positions (long or short), effect transactions or make markets in securities or financial instruments mentioned herein (or related instruments), or provide advice or loans to, or participate in the underwriting or restructuring of the obligations of, the legal entities mentioned herein. The Sales and Trading personnel who prepared this material may be compensated in part based on trading activity. Moreover, Sales and Trading personnel may have acted on the basis of this material either on behalf of J.P. Morgan or, where permitted, in their personal accounts. As such, this material should not be relied upon as either objective or independent from the interests of J.P. Morgan and its associated personnel, which interests may conflict with your interests.
Securities, financial instruments or strategies mentioned herein may not be available in all jurisdictions or to all clients. Clients should contact their salespersons at, and execute transactions through, a J.P. Morgan entity appropriately licensed in the client’s home jurisdiction unless governing law permits otherwise.
Product names, company names and logos mentioned herein are trademarks or registered trademarks of their respective owners.
For important disclosures in respect of wholesale fixed income, currency, commodities and equities products, please see: https://www.jpmorgan.com/disclosures/ficcequities. Electronic trading with J.P. Morgan is subject to our standard electronic trading terms of service.
J.P. Morgan is a marketing name for investment banking businesses of JPMorgan Chase & Co. and its subsidiaries and affiliates worldwide. Bank products and services, including certain lending, derivative and other commercial banking activities, are offered by JPMorgan Chase Bank N.A. (JPMCB), including through its authorized branches and other global affiliates registered with local authorities as appropriate. Securities products and services, including execution services, are offered in the United States and in other jurisdictions worldwide by J.P. Morgan Securities LLC (JPMS LLC), in EMEA by J.P. Morgan Securities plc (JPMS plc), J.P. Morgan SE (JPM SE) and by other appropriately licensed global affiliates. JPMCB, JPMS LLC, JPMS plc and JPM SE are principal subsidiaries of JPMorgan Chase & Co. For information on which legal entities offer investment banking products and services in each jurisdiction, please consult: www.jpmorgan.com/ib-legal-entities. For important disclosures in respect of securities transactions, please consult: www.jpmorgan.com/securities-transactions and in respect of over-the-counter equity derivatives transactions, please consult: www.jpmorgan.com/otc-equity-derivative-transactions.
Country Specific Disclosures
Brazil: J.P. Morgan Ombudsman: 0800-7700847. E-mail: firstname.lastname@example.org. Singapore: For important Singapore disclosures, please consult: https://www.jpmorgan.com/disclosures/apac-legal-entity-information. South Africa: J.P. Morgan Securities plc is exempt from the licensing provisions of the Financial Advisory and Intermediary Services Act, 2002.